If we had disregarded a weak to moderate arginase-1 immunostaining limited to the cytoplasm (non-nuclear) in samples from the liver, we would not have recorded any arginase-1 positivity in cholangiocellular carcinomas. Here, ARG1 is linked to cholangiocarcinoma.